Evidence map›Paper›PMID 40003987›Full record

ArticleInternational journal of molecular sciences2025

Vitisin A Outperforms Cyanidin-3-O-Glucoside in Triglyceride Reduction by Modulating Hepatic Lipogenesis and Fatty Acid β-Oxidation.

Yawen Li, Xusheng Li, Jia Liu, Pallavi Jayavanth, Weibin Bai, Rui Jiao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yawen LiDepartment of Food Science and Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
Xusheng LiDepartment of Food Science and Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.ORCID 0000-0003-3339-685X
Jia LiuDepartment of Food Science and Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
Pallavi JayavanthDepartment of Food Science and Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
Weibin BaiDepartment of Food Science and Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
Rui JiaoDepartment of Food Science and Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.

Funding

Applied Basic Research Foundation of Guangdong Province 2019A1515010683Basic and Applied Basic Research Foundation of Guangdong Province No. 2023A1515012551Department of Science and Technology of Guangdong Province KTP20210129National Natural Science Foundation of China 32272310
6 · The paper itself

Abstract

Pyranoanthocyanins exhibit greater bioactivity compared to monomeric anthocyanins, yet the lipid-lowering effects of pyranoanthocyanin Vitisin A, a primary derivative found in aged red wines, have not been extensively studied in vivo. This study evaluated the triglyceride-lowering effects of Vitisin A and its anthocyanin counterpart Cyanidin-3-O-glucoside (C3G) in both free fatty acid -induced HepG2 cells and high-fat diet-fed ApoE

Indexed as

AnthocyaninsFatty AcidsGlucosidesLipogenesisLiverTriglyceridesAnimalsDiet, High-FatHep G2 CellsHumansLipid MetabolismMaleMiceMice, Inbred C57BLOxidation-ReductionSignal TransductionAnthocyaninscyanidin-3-O-beta-glucopyranosideFatty AcidsGlucosidesTriglyceridesfatty acid synthesispyranoanthocyanintriglyceridevitisin Aβ-oxidation

Identifiers

PMID40003987
PMCPMC11855501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.